Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Sheehan

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinomaAndrew X Zhu, Lawrence S Blaszkowsky, David P Ryan, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2010
Succinic acid amides as P2-P3 replacements for inhibitors of interleukin-1beta converting enzyme (ICE or caspase 1)Paul Galatsis, Bradley Caprathe, John Gilmore, et al.
Journal of the American Society of Nephrology : JASN|March 30, 2016
Loss of Kynurenine 3-Mono-oxygenase Causes ProteinuriaRon Korstanje, Konstantin Deutsch, Patricia Bolanos-Palmieri, et al.
Investigational New Drugs|September 25, 2014
A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular carcinomaLipika Goyal, Raymond C Wadlow, Lawrence S Blaszkowsky, et al.
Aging Cell|April 13, 2017
Caenorhabditis elegans orthologs of human genes differentially expressed with age are enriched for determinants of longevityGeorge L Sutphin, Grant Backer, Susan Sheehan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancerJeffrey A Meyerhardt, Andrew X Zhu, Peter C Enzinger, et al.
American Journal of Physiology. Renal Physiology|August 4, 2012
Genetic analysis of albuminuria in collaborative cross and multiple mouse intercross populationsJill Thaisz, Shirng-Wern Tsaih, Minjie Feng, et al.
Hospital Topics|September 2, 2021
Inpatient Capacity Management during COVID-19 Pandemic: The Yale New Haven Hospital Capacity Expansion ExperienceRobert L Fogerty, Michael Aniskiewicz, Todd Hedges, et al.
Nature Communications|December 14, 2023
On the benefits of the tryptophan metabolite 3-hydroxyanthranilic acid in Caenorhabditis elegans and mouse agingHope Dang, Raul Castro-Portuguez, Luis Espejo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2013
Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II studyAndrew X Zhu, Marek Ancukiewicz, Jeffrey G Supko, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinomaAndrew X Zhu, Lawrence S Blaszkowsky, David P Ryan, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2010
Succinic acid amides as P2-P3 replacements for inhibitors of interleukin-1beta converting enzyme (ICE or caspase 1)Paul Galatsis, Bradley Caprathe, John Gilmore, et al.
Journal of the American Society of Nephrology : JASN|March 30, 2016
Loss of Kynurenine 3-Mono-oxygenase Causes ProteinuriaRon Korstanje, Konstantin Deutsch, Patricia Bolanos-Palmieri, et al.
Investigational New Drugs|September 25, 2014
A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular carcinomaLipika Goyal, Raymond C Wadlow, Lawrence S Blaszkowsky, et al.
Aging Cell|April 13, 2017
Caenorhabditis elegans orthologs of human genes differentially expressed with age are enriched for determinants of longevityGeorge L Sutphin, Grant Backer, Susan Sheehan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancerJeffrey A Meyerhardt, Andrew X Zhu, Peter C Enzinger, et al.
American Journal of Physiology. Renal Physiology|August 4, 2012
Genetic analysis of albuminuria in collaborative cross and multiple mouse intercross populationsJill Thaisz, Shirng-Wern Tsaih, Minjie Feng, et al.
Hospital Topics|September 2, 2021
Inpatient Capacity Management during COVID-19 Pandemic: The Yale New Haven Hospital Capacity Expansion ExperienceRobert L Fogerty, Michael Aniskiewicz, Todd Hedges, et al.
Nature Communications|December 14, 2023
On the benefits of the tryptophan metabolite 3-hydroxyanthranilic acid in Caenorhabditis elegans and mouse agingHope Dang, Raul Castro-Portuguez, Luis Espejo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2013
Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II studyAndrew X Zhu, Marek Ancukiewicz, Jeffrey G Supko, et al.
Pageof 4